enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ubrogepant - Wikipedia

   en.wikipedia.org/wiki/Ubrogepant

   Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. [ 4 ] [ 5 ] It is not indicated for the preventive treatment of migraine. [ 6 ]

3. Drug coupon - Wikipedia

   en.wikipedia.org/wiki/Drug_Coupon

   Drug coupons reduce out-of-pocket costs for consumers in a variety of ways such as instant savings offers, free trial offers (also known as try-before-you-buy offers), copay reduction or rebates. Generic drug companies rarely offer coupons, though insurance companies occasionally offer discounts on generic drugs.

4. Co-pay card - Wikipedia

   en.wikipedia.org/wiki/Co-pay_card

   The patient provides his/her insurance card and co-pay card to the pharmacist. The pharmacist enters information into his/her pharmacy management system from both cards. The insurance benefit manager recognizes the drug as a TIER 3 brand for the patient and relays the patient co-pay to be $30.00.

5. J&J's chemotherapy-free treatment for lung cancer gets US ...

   www.aol.com/news/us-fda-approves-j-js-111733970.html

   The approval allows the use of the cancer drug, Rybrevant, in combination with J&J's existing drug, lazertinib, as a first-line treatment for non-small cell lung cancer (NSCLC) patients with a ...

6. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   In combination with palbociclib and fulvestrant for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth-factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant ...

7. 'Unprecedented' cancer treatment making patients symptom-free

   www.aol.com/news/2016-02-16-unprecedented-cancer...

   Researchers are calling early trials of a treatment using patients' immune cells to fight cancer "unprecedented." In one study by an international team of scientists, the symptoms of severe ...

8. Galcanezumab - Wikipedia

   en.wikipedia.org/wiki/Galcanezumab

   Trial three enrolled participants with a history of chronic migraine headaches. [10] Participants were assigned to receive galcanezumab or placebo injection once a month for three months. [ 10 ] Neither the participants nor the health care providers knew which treatment was being given until after the trial was completed. [ 10 ]

9. Bi-specific T-cell engager - Wikipedia

   en.wikipedia.org/wiki/Bi-specific_T-cell_engager

   Bi-specific T-cell engager (BiTE) is a class of artificial bispecific monoclonal antibodies that are investigated for use as anti-cancer drugs. They direct a host's immune system, more specifically the T cells ' cytotoxic activity, against cancer cells.